Preparation method of steroid hormone intermediate
In the preparation process of steroid hormone intermediates, the electrophilic addition reaction is performed using catalysts and small molecule acid salts to change the solvent and feeding method, and the problems of low yield and purity in the prior art are solved, achieving high efficiency Material utilization and wastewater reduction have improved production efficiency.
Patent Information
- Application Number
- CN202411127746.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-08
AI Technical Summary
In the prior art, the yield and purity of steroid hormone intermediates are relatively low, and the solvent use efficiency is low, resulting in large material losses and wastewater discharge, affecting environmental protection and production efficiency.
Under the action of a catalyst, the compound undergoes electrophilic addition reaction with a halogenating agent and a small molecule acid. By changing the reaction solvent and addition method, by controlling by-products and impurities, improving yield and purity, and through anhydrous formic acid and small molecule acid The use of salt reduces the amount of wastewater and impurity content.
The total yield has been increased to 86%, the wastewater discharge has been reduced, the production costs have been reduced, the overall efficiency of the enterprise has been improved, and the yield and purity of the product has been significantly improved.
Smart Images

Figure CN118909024A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of steroid hormone drug preparation, and specifically relates to a method for preparing a steroid hormone intermediate. Background Art
[0002] The structural formula of steroid hormone intermediate is as follows:
[0003] R2=α-CH3, named 8DM; R2=β-CH3, named DB11.
[0004] DB11 is a key intermediate in the synthesis of betamethasone. Its chemical name is 9β,11β-epoxy-16β-methylpregnane-1,4-diene-17α,21-diol-3,20-dione. Betamethasone is a steroid compound, mainly used as an adrenal cortex hormone drug.
[0005] 8DM is a key intermediate in the synthesis of dexamethasone, with the chemical name: 9β,11β-epoxy-16α-methylpregnane-1,4-diene-17α,21-diol-3,20-dione. Like betamethasone, dexamethasone has pharmacological effects such as anti-inflammatory, anti-endotoxin, immunosuppressive, anti-shock and enhanced stress response.
[0006] Patent application CN112028965A discloses a method for preparing betamethasone epoxide, and the reaction route is:
[0007] This route adopts the "one-pot method". Although it simplifies the operating procedures, a large amount of ammonia nitrogen-containing solvent DMF is used in the raw and auxiliary materials. The solvent enters the water phase and cannot be recycled and reused. In addition, water is dripped into the DMF system during the refining and discharging. DMF has a strong dissolving ability. Although it has a refining effect, the material loss is large and the overall yield is not high. In addition, the refined mother liquor water and DMF, as well as the material are mixed, cannot effectively separate and recover the material and the organic solvent, resulting in great waste and environmental pressure.
[0008] Patent application CN104945464A discloses a method for synthesizing betamethasone epoxy hydrolyzate, and the synthetic route is:
[0009] This route is mainly aimed at improving the low yield of the original process. However, after carefully studying the raw materials, auxiliary materials, solvents, and water precipitation ratios of this process, it was found that the water precipitation multiple of this process is very large (the ratio of substrate to water precipitation is about 1:42), and the wastewater after water precipitation contains dioxane and water-miscible solvents that are difficult to recover, causing great waste. In addition, the theoretical mass yield of this route is 93%. After improvement, this route will increase the yield from 65% to 70-75%, but it is still low.
[0010] Patent application CN103588853 A discloses a method for preparing 9,11β-epoxy steroid compounds, and the reaction route is:
[0011] Its yield and purity need to be further improved. Summary of the invention
[0012] The technical problem to be solved by the present invention is to provide a method for preparing a steroid hormone intermediate, so as to further improve the yield and purity.
[0013] The embodiment of the present invention provides a method for preparing a steroid hormone intermediate. In a solvent, compound I reacts with a halogenating agent and a small molecule acid (electrophilic addition reaction) under the action of a catalyst to obtain a steroid hormone intermediate. The reaction route is as follows: ; The catalyst comprises an acid and a small molecule acid salt, wherein the acid is a strong acid or a medium-strong acid, the small molecule acid is formic acid or acetic acid; and the small molecule acid salt is a formate or an acetate; R1 is CHO- or CH3CO-, R2 is hydrogen or C 1-6 Alkyl, R3 is hydrogen or C 1-6 wherein X is halogen.
[0014] Preferably, R2 is β-CH3 or α-CH3, R3 is methyl, and X is Br.
[0015] Preferably, the acid is perchloric acid, fluoroboric acid, phosphoric acid or sulfuric acid (preferably perchloric acid).
[0016] Preferably, the formate is one or more of lithium formate, sodium formate, ammonium formate, and potassium formate (preferably lithium formate), and the acetate is one or more of lithium acetate, sodium acetate, ammonium acetate, and potassium acetate (preferably lithium acetate).
[0017] Preferably, the solvent includes one or more of dichloromethane, formic acid, acetic acid, tetrahydrofuran, and 2-methyltetrahydrofuran, preferably tetrahydrofuran.
[0018] Preferably, the halogenating agent is dibromohydantoin or N-bromosuccinimide (preferably dibromohydantoin).
[0019] Preferably, the weight-to-volume ratio of the compound I and the solvent is 1 g:3-10 ml, the molar ratio of the compound I and the halogen atoms in the halogenating agent is 1:1.2-2, the weight ratio of the acid and the small molecule acid salt is 1.2-2.55:1, and the molar ratio of the compound I and the acid is 1:1.3-4.5.
[0020] Preferably, the weight-to-volume ratio of the compound I and the solvent is 1 g:3-5 ml, the molar ratio of the compound I and the halogen atoms in the halogenating agent is 1:1.2-1.75, the weight ratio of the acid and the small molecule acid salt is 1.2-1.65:1, and the molar ratio of the compound I and the acid is 1:1.55-3.25.
[0021] Preferably, the reaction temperature is -10-30°C, and during the reaction, the halogenating agent is added dropwise into the solvent containing compound I.
[0022] Preferably, the solvent also includes dichloromethane.
[0023] Preferably, the solvent is anhydrous formic acid, the catalyst is perchloric acid and lithium formate, and the halogenating agent is dibromohydantoin.
[0024] Preferably, compound II and a base undergo a ring-closing reaction to obtain compound III, and the structural formula of compound III is as follows: , The base is carbonate, sodium hydroxide or potassium hydroxide, and the solvent for the ring-closing reaction is chloroform, dichloromethane, methanol or ethanol.
[0025] Preferably, the molar ratio of compound II to the base is 1: 1.0-5.0, the reaction temperature is -10-55°C, and the mass ratio of compound II to the solvent is 1: 5.0-25.
[0026] Preferably, the compound III undergoes a hydrolysis reaction with a base to obtain a compound IV, and the structural formula of the compound IV is as follows: , The base is carbonate, sodium hydroxide or potassium hydroxide, and the solvent for the hydrolysis reaction is chloroform, dichloromethane, methanol or ethanol.
[0027] Preferably, the molar ratio of compound III to the base is 1: 1.0-5.0, the reaction temperature is -10-70°C, and the mass ratio of compound III to the solvent is 1: 1.0-30.
[0028] The beneficial effect of the present invention is that the inventors have found that in the preparation method of compound II, when the bromide ions in the halogenating agent such as dibromohydantoin or N-bromosuccinimide (NBS) in the reaction system reach a certain concentration, the bromide ions form a competitive reaction with water. When the bromide ion concentration is too high, a by-product dibrominate is generated, that is, the substituents on 9-11 are all bromide ions.
[0029] Based on the prior art, the present invention controls byproducts (such as dibromine) well and improves the total yield by changing the reaction solvent, adding catalyst, feeding method and post-treatment. It achieves the effects of high yield, solvent recycling, reduced wastewater discharge, etc., reduces production costs and improves the comprehensive benefits of the enterprise.
[0030] Why is the yield of the bromohydroxy reaction still low under the premise of a high substrate conversion rate? There are two reasons: First, after the reaction system is filtered after water precipitation, because there is still solvent in the water phase, the solvent has a certain solubility in the product, and there is still material leakage, resulting in a low yield. It is unreasonable to simply increase the water precipitation multiple. Second, the by-products and impurities are not effectively controlled and refined into the mother liquor, resulting in a low overall yield.
[0031] The present invention prepares a halogenating agent, such as a bromine reagent, into a solution with an organic solvent and then slowly drips the solution into the reaction system, thereby greatly reducing the release rate of bromide ions in the reaction system and controlling the dibromo impurities well. The existing conventional method is basically based on a large amount of water precipitation, which is mainly due to the bromohydrin (compound II, R1 = H). The compound has poor stability and cannot be concentrated and removed from the solvent under heating conditions, so water precipitation is the only option. The present invention selects different reagents (anhydrous formic acid, anhydrous sodium formate, acetic acid, etc.) to prepare compound II (R1 = CHO-, CH3CO-). After terminating the reaction, the solvent is concentrated and removed, and a small amount of water is added for filtration. It has the advantages of small by-products, high yield, and less wastewater.
[0032] In the present invention, anhydrous formic acid is added to participate in the reaction, and the obtained compound II has R1 as CHO-, and the stability of the compound is greatly improved.
[0033] The present invention adds a small molecule acid, such as formic acid or acetic acid, and uses formic acid or acetic acid as a solvent, or uses tetrahydrofuran or 2-methyltetrahydrofuran as a solvent. On the one hand, the boiling point of the solvent is low, it is easier to remove, and the amount of wastewater is small; on the other hand, the yield and purity of the product are higher. Compared with the use of solvents such as dimethylformamide and esterification agents, the amount of wastewater is significantly reduced, the yield and purity are improved, and the impurity content is reduced.
[0034] The present invention also adds a small molecule acid salt, which forms a synergistic effect with formic acid or acetic acid, making the reaction easier to carry out, the raw material reaction more thorough, and the yield and purity can be improved.
[0035] The present invention uses 9,11 elimination products as raw materials, which are easily available. By adding materials, the byproduct (dibromo product) is effectively controlled. By changing auxiliary materials and solvents, the thermal stability of the substrate is enhanced, the solvent is concentrated and removed, the amount of water precipitation is reduced, the post-processing operation is simple, the solvent can be recycled and reused, and the total yield is increased to 86%. The problems of large byproducts, low yield, large amount of water precipitation, and more nitrogen-containing wastewater in the prior art are solved. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 This is the HNMR spectrum of compound IV (R2=α-CH3).
[0037] Figure 2 This is the C-NMR diagram of compound IV (R2=α-CH3). DETAILED DESCRIPTION
[0038] Example 1 Step 1: Preparation of Compound II Add 400ml of tetrahydrofuran to a three-necked flask, cool to -5~0℃, add 25g of anhydrous formic acid, 20g of lithium formate, 5ml of perchloric acid, add 100g of compound Ⅰ (R2 is methyl, R3 is methyl), dissolve 55g of dibromohydantoin in 165ml of dichloromethane, and slowly add it to the reactor in a constant pressure dropping funnel at 0℃. Control the dropping time for 150 minutes. After the addition is completed, control the temperature at 0~5℃, react for 3.5 hours, and control it by TLC. After confirming that the raw material has reacted completely, slowly pour the reaction solution into 300ml of sodium sulfite aqueous solution, stir for 30 minutes, concentrate the dichloromethane under reduced pressure at 35℃, and filter to obtain a white solid with a weight yield of 155%, HPLC purity of 98.5%, impurities <0.5%, of which the dibromo impurity is 0.10%, and the substrate remains 0.05%. The wet material does not need to be dried and is directly used for the next step of cyclization.
[0039] Step 2: Preparation of Compound III Under nitrogen protection, 300ml methanol and 1000ml dichloromethane were pumped into the three-necked flask, and all the compound II (R1 is CHO-, X is Br) was added, stirred evenly, and the temperature was controlled at 20-25℃. 70g of 40% potassium carbonate aqueous solution was slowly added to the reaction bottle, and the reaction was kept at 40℃ for 2.5 hours. Samples were taken, and the raw materials should be basically reacted completely by TLC detection. 10ml glacial acetic acid was added dropwise to the reaction solution to terminate the reaction, the pH was adjusted to neutral, stirred for 10 minutes, and the reaction solution was transferred to a separatory funnel, separated, the aqueous phase was discarded, and the organic phase was concentrated under reduced pressure to a paste, and methanol was added for replacement twice, 60ml of methanol each time, and after concentration, filtered to obtain a white solid crude product with HPLC purity>98%. No drying was required, and it was directly hydrolyzed.
[0040] Step 3: Preparation of Compound IV Under nitrogen protection, 800ml of chloroform and 260ml of methanol were pumped into a three-necked flask, and all the crude epoxy products were added. 30g of 30% sodium sulfite aqueous solution was added to the hydrolysis bottle. After the addition was completed, the reaction was kept at 60℃ for 2.5 hours, and samples were taken. The raw materials should be basically reacted completely by TLC detection. 2ml of glacial acetic acid was added to the reaction solution to terminate the reaction, the pH was adjusted to neutral, and stirred for 10 minutes. The reaction solution was transferred to a separatory funnel, separated, the aqueous phase was discarded, and the organic phase was concentrated under reduced pressure to a paste. Methanol was added for replacement twice, 100ml of methanol each time, and after concentration, filtration was completed to obtain 86g of compound IV, with HPLC purity>99%. The total mass yield calculated based on compound I was 86%.
[0041] Example 2 Compared with step 1 of Example 1, the difference is that lithium formate is replaced by sodium formate, and the rest is the same as Example 1. The weight yield of step 1 is 150%, HPLC purity is 97.5%, impurities are 2.5%, of which the dibromo impurity is 0.23%, and the substrate remains 0.15%.
[0042] Comparative Example 1 Step 1: Preparation of Compound II The difference from Example 1 is that lithium formate is not added, and the other steps are the same as step 1 of Example 1.
[0043] The weight yield was 146%, the HPLC purity was 94%, the substrate remained at 2%, and the impurities were 4.0%, of which the dibromo impurity was 0.55%.
[0044] Comparative Example 2 Step 1: Preparation of Compound II The difference from Example 1 is that the dibromohydantoin solid is added in three portions; That is, after adding 100 g of compound I, 55 g of dibromohydantoin was added in 3 portions, with the temperature controlled at 0°C, once every 15 minutes, and 18.3 g was added each time. The rest was the same as in Example 1.
[0045] The weight yield of step 1 is 149%, the HPLC purity is 95%, the substrate remains 2%, and the impurities are 3.0%, of which the dibromo impurity is 2.5%.
[0046] Comparative Example 3 On the basis of Comparative Example 1, anhydrous formic acid was replaced with dimethylformamide, and the rest was the same as Comparative Example 1.
[0047] The weight yield of step 1 is 135%, the HPLC purity is 97.8%, the substrate remains 0.2%, the impurity is 2.0%, of which the dibromo impurity is 0.85%.
[0048] A person skilled in the art should understand that the discussion of any of the above embodiments is merely illustrative and is not intended to imply that the scope of protection of the present application is limited to these examples. In line with the concept of the present application, the technical features in the above embodiments or different embodiments may be combined, the steps may be implemented in any order, and there are many other variations of different aspects of one or more embodiments of the present application as described above, which are not provided in detail for the sake of simplicity.
[0049] One or more embodiments of the present application are intended to cover all such substitutions, modifications and variations that fall within the broad scope of the present application. Therefore, any omissions, modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of one or more embodiments of the present application should be included in the protection scope of the present application.
Claims
1. A method for preparing a steroid hormone intermediate, characterized in that In a solvent, compound I reacts with a halogenating agent and a small molecule acid under the action of a catalyst, and is treated to obtain a steroid hormone intermediate; the reaction route is as follows: ; The catalyst comprises an acid and a small molecule acid salt, wherein the acid is a strong acid or a medium-strong acid; the small molecule acid is formic acid or acetic acid; and the small molecule acid salt is formate or acetate; R1 is CHO- or CH3CO-, R2 is hydrogen or C 1-6 Alkyl, R3 is hydrogen or C 1-6 wherein X is halogen.
2. The preparation method according to claim 1, characterized in that: R2 is β-CH3 or α-CH3, R3 is methyl, and X is Br.
3. The preparation method according to claim 1, characterized in that: The acid is perchloric acid, fluoroboric acid, phosphoric acid or sulfuric acid.
4. The preparation method according to claim 1, characterized in that: The formate is one or more of lithium formate, sodium formate, ammonium formate, and potassium formate; the acetate is one or more of lithium acetate, sodium acetate, ammonium acetate, and potassium acetate.
5. The preparation method according to claim 1, characterized in that: The solvent includes one or more of dichloromethane, formic acid, acetic acid, tetrahydrofuran, and 2-methyltetrahydrofuran.
6. The preparation method according to claim 1, characterized in that: The halogenating agent is dibromohydantoin or N-bromosuccinimide.
7. The preparation method according to claim 1, characterized in that: The weight-to-volume ratio of the compound I to the solvent is 1 g:3-10 ml, the molar ratio of the compound I to the halogen atoms in the halogenating agent is 1:1.2-2, the weight ratio of the acid to the small molecule acid salt is 1.2-2.55:1, and the molar ratio of the compound I to the acid is 1:1.3-4.
5.
8. The preparation method according to claim 7, characterized in that: The weight-to-volume ratio of the compound I to the solvent is 1 g:3-5 ml, the molar ratio of the compound I to the halogen atom in the halogenating agent is 1:1.2-1.75, the weight ratio of the acid to the small molecule acid salt is 1.2-1.65:1, and the molar ratio of the compound I to the acid is 1:1.55-3.
25.
9. The preparation method according to any one of claims 1 to 8, characterized in that: Compound II and base undergo a cyclization reaction to obtain compound III, the structural formula of which is as follows: , The base is carbonate, sodium hydroxide or potassium hydroxide, and the solvent for the ring-closing reaction is chloroform, dichloromethane, methanol or ethanol.
10. The preparation method according to claim 9, characterized in that: The compound III undergoes a hydrolysis reaction with a base to obtain a compound IV, and the structural formula of the compound IV is as follows: , The base is carbonate, sodium hydroxide or potassium hydroxide, and the solvent for the hydrolysis reaction is chloroform, dichloromethane, methanol or ethanol.
